
Cytomine
Collaborative platform for biomedical image analysis with cloud hosting and machine learning integration.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | Seed | ||
Total Funding | 000k |
EUR | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Cytomine is a cooperative that specializes in providing an open-source, web-based platform for collaborative biomedical image analysis. The company serves a diverse range of clients including academic institutions, research organizations, and healthcare providers. Operating in the biomedical and educational markets, Cytomine offers a subscription-based model for its cloud-hosted services, which include advanced image analysis and machine learning algorithms. This model ensures a steady revenue stream while providing clients with scalable and efficient solutions for their imaging needs. By importing microscope images and image analysis software into a web browser, Cytomine enhances the capabilities of pathologists, researchers, and educators, enabling them to improve health, science, and education outcomes. The platform's features include multi-gigapixel image support, straightforward annotation tools, and compatibility with various image formats, making it a versatile tool for its users.
Keywords: biomedical, image analysis, cloud hosting, machine learning, pathology, research, education, open-source, web-based, collaborative.